| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 |
____________________________
FORM 6-K
____________________________
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
July 7, 2016
____________________________
Lombard Medical, Inc.
(Exact Name of Registrant as Specified in Its Charter)
Commission File Number 001-36402
____________________________
N/A
(Translation of Registrant’s Name into English)
____________________________
| Cayman Islands (State or Other Jurisdiction of Incorporation or Organization) | 3841 (Primary Standard Industrial Classification Code Number) | Not applicable (I.R.S. Employer Identification Number) |
6440 Oak Canyon
Suite 200
Irvine, CA 92618
+1-866-790-1447
(Address, Including ZIP Code, and Telephone Number, Including Area Code, of Registrant’s Principal Executive Offices)
_______________________
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F [ X ] Form 40-F [ ]
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ___
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ___
On June 30, 2016, Lombard Medical, Inc. (the “Company”) announced that it plans to hold its 2016 Annual General Meeting of Shareholders (the “Annual Meeting”) on August 2, 2016 at 10:00 a.m., Pacific Time, at the Company’s U.S. office located at 6440 Oak Canyon, Suite 200, Irvine, California 92618.
Pursuant to the Company’s Amended and Restated Memorandum and Articles of Association, the Company mailed a Notice of Annual Meeting and accompanying proxy statement to the Company’s shareholders of record as of July 1, 2016, copies of which are attached hereto and incorporated by reference herein.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| Lombard Medical, Inc. | ||
| Date: July 7, 2016 | By: | /s/ William J. Kullback |
| William J. Kullback Chief Financial Officer | ||
INDEX TO EXHIBITS
| Exhibit No. | Description |
| 99.1 | Notice of Annual Meeting and Proxy Statement |